← All organizations

Rho, Inc.

For profitWebsite ↗

Also known as: Rho Federal Systems Division, Inc. | Rho, Inc. | Rho Incorporated

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Feb 18, 2026

Timeline

1980s

Jun 1, 1984
Rho, Inc.— Founded

Drugs by trial phase (51 distinct, 40 trials)

Phase 4 (1 own, 0 via acquisition)

ocrelizumab

Phase 3 (8 own, 0 via acquisition)

Phase 2 (39 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (40)

NCT07015996CollaboratorPhase 2Feb 18, 2026
NCT07103746CollaboratorPhase 2Nov 30, 2025
NCT06504160CollaboratorPhase 2Dec 15, 2024
NCT06560151CollaboratorPhase 2Aug 21, 2024
NCT06366087CollaboratorPhase 1Apr 15, 2024
NCT06254612CollaboratorPhase 2Mar 25, 2024
NCT05997264CollaboratorPhase 2Dec 5, 2023
NCT05671757CollaboratorPhase 1/Phase 2May 26, 2023
NCT05686408CollaboratorPhase 2Mar 2, 2023
NCT05796765CollaboratorPhase 2Feb 17, 2023
NCT05631626CollaboratorPhase 3Dec 31, 2022
NCT05668754CollaboratorPhase 2Dec 22, 2022
NCT05285891CollaboratorPhase 4Dec 16, 2022
NCT05347771CollaboratorPhase 2May 4, 2022
NCT05017545CollaboratorPhase 1/Phase 2Nov 30, 2021

Details

Founded: Chapel Hill, NC, US Jun 1, 1984
Last known activity: Feb 18, 2026

Notes

CRO